AIRFLOW 125 Inh is a combination inhaler containing Salmeterol 25 mcg and Fluticasone 125 mcg, designed for the effective management of asthma and chronic obstructive pulmonary disease (COPD). This dual-action inhaler combines the benefits of a long-acting bronchodilator (Salmeterol) with an anti-inflammatory corticosteroid (Fluticasone) to provide both immediate and long-term relief from respiratory symptoms.
Asthma and COPD are chronic respiratory conditions that affect millions of people worldwide, leading to wheezing, shortness of breath, chest tightness, and frequent coughing. AIRFLOW 125 Inh works by relaxing the muscles in the airways, reducing inflammation, and improving airflow to the lungs. Its combination therapy approach ensures better control of symptoms, reduces the risk of flare-ups, and enhances overall lung function.
Uses
AIRFLOW 125 Inh is primarily prescribed for patients with persistent asthma or COPD, especially when monotherapy is insufficient. Its key uses include:
Asthma Management: Helps control chronic asthma symptoms in adults and adolescents.
Chronic Obstructive Pulmonary Disease (COPD): Supports breathing in patients with COPD by reducing airway constriction.
Prevention of Asthma Attacks: Reduces the frequency and severity of asthma exacerbations.
Anti-Inflammatory Action: Fluticasone suppresses airway inflammation, preventing long-term lung damage.
Long-Term Symptom Control: Provides sustained bronchodilation and airway protection for better daily life function.
AIRFLOW 125 Inh is not intended for immediate relief of acute asthma attacks. It is meant for maintenance therapy and long-term respiratory control.
Benefits
AIRFLOW 125 Inh offers several significant benefits, making it a preferred choice for patients with asthma or COPD:
Dual Mechanism of Action: Salmeterol relaxes airway muscles, while Fluticasone reduces inflammation.
Improved Breathing: Enhances airflow, making breathing easier and reducing wheezing.
Prevents Exacerbations: Decreases the risk of severe asthma attacks and COPD flare-ups.
Long-Acting Relief: Salmeterol provides sustained bronchodilation for up to 12 hours.
Reduced Steroid Side Effects: Inhaled Fluticasone targets the lungs directly, minimizing systemic exposure.
Enhanced Quality of Life: Supports daily activities without frequent breathlessness.
Convenient Dosing: Typically used twice daily, ensuring effective maintenance therapy.
The combination of a LABA (long-acting beta-agonist) and ICS (inhaled corticosteroid) in AIRFLOW 125 Inh ensures comprehensive symptom control and lung protection.
Dosage
The dosage of AIRFLOW 125 Inh should always be determined by a healthcare professional based on the severity of the respiratory condition and the patient’s response to therapy.
Typical Adult Dose: 1–2 inhalations twice daily, approximately 12 hours apart.
Adolescents (12 years and above): Same as adult dosing unless otherwise directed by a physician.
Important Instructions:
Shake the inhaler well before each use.
Exhale fully before inhaling the medication.
Press the inhaler to release the dose while inhaling deeply and slowly.
Hold your breath for 5–10 seconds after inhalation.
Rinse your mouth with water after each dose to reduce the risk of oral thrush.
Patients should follow the prescribed schedule and not use AIRFLOW 125 Inh for immediate relief. For sudden asthma attacks, a short-acting inhaler should be used as directed by a doctor.
Side Effects
AIRFLOW 125 Inh is generally well tolerated, but some patients may experience side effects, including:
Common Side Effects:
Throat irritation
Hoarseness or voice changes
Mild cough
Oral thrush (fungal infection in the mouth)
Headache
Less Common or Serious Side Effects:
Rapid or irregular heartbeat
Chest pain
Severe allergic reactions, including rash, swelling, or difficulty breathing
Muscle cramps or tremors
If any severe or persistent side effects occur, patients should seek medical attention immediately. Regular follow-up with a healthcare professional is advised to monitor lung function and inhaler technique.
Precautions and Warning
Before starting AIRFLOW 125 Inh, patients should observe the following precautions and warnings:
Not for Acute Relief: Do not use this inhaler for sudden asthma attacks. Keep a rescue inhaler nearby.
Allergies: Inform your doctor of any known allergies to Salmeterol, Fluticasone, or other medications.
Heart Conditions: Use with caution in patients with heart disease, high blood pressure, or irregular heart rhythms.
Diabetes and Thyroid Disorders: Long-term use may affect blood sugar or thyroid hormone levels.
Infections: Avoid using if you have a lung infection or tuberculosis unless prescribed by a doctor.
Pregnancy and Breastfeeding: Only use if clearly indicated and supervised by a healthcare professional.
Medication Interactions: Inform your doctor about all medications, including antifungals, antivirals, or other corticosteroids.
Proper inhaler technique, adherence to the prescribed schedule, and routine monitoring are essential for safe and effective use.
Conclusion
AIRFLOW 125 Inh (Salmeterol 25 mcg & Fluticasone 125 mcg) is a highly effective combination inhaler designed for the long-term management of asthma and COPD. By combining a long-acting bronchodilator with an inhaled corticosteroid, AIRFLOW 125 Inh provides dual-action relief: it opens the airways, reduces inflammation, and helps prevent exacerbations.
When used as prescribed, AIRFLOW 125 Inh enhances lung function, reduces the frequency of attacks, and significantly improves the quality of life for patients with chronic respiratory conditions. Along with lifestyle modifications, proper inhaler technique, and regular medical supervision, this inhaler serves as a reliable and convenient option for maintaining optimal respiratory health and controlling chronic asthma and COPD symptoms.
